v3.25.2
SEGMENTED INFORMATION
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
SEGMENTED INFORMATION

14. SEGMENTED INFORMATION

 

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. The Company has two reportable segments based on business unit, investment holding and health care products and services and two reportable segments based on country, Malaysia and Non-Malaysia.

 

The Company adopted the ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.

 

In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes.

By Business Unit  Investment
holding		   Health care
products
and services		   Total 
   For the period ended June 30, 2025 
By Business Unit  Investment
holding		   Health care
products
and services		   Total 
             
Revenue  $-   $2,022,526   $2,022,526 
Cost of revenue   -    (1,610,871)   (1,610,871)
Gross profit   -    411,655    411,655 
Selling, general and administrative expenses and other income   (32,351)   (190,686)   (223,037)
Finance cost   -    (6,120)   (6,120)
Lease expense   -    (7,500)   (7,500)
Profit from operations   (32,351)   207,349    174,998 
                
Total assets  $40,887   $910,835   $951,722 
Capital expenditure  $-   $2,392   $2,392 

 

By Country  Malaysia   Non-Malaysia   Total 
   For the period ended June 30, 2025 
By Country  Malaysia   Non-Malaysia   Total 
             
Revenue  $2,022,526   $-   $2,022,526 
Cost of revenue   (1,610,871)   -    (1,610,871)
Gross profit   411,655    -    411,655 
Selling, general and administrative expenses and other income   (188,658)   (34,379)   (223,037)
Finance cost   (6,120)   -    (6,120)
Lease expense   (7,500)   -    (7,500)
Profit from operations   209,377    (34,379)   174,998 
                
Total assets  $851,707   $100,015   $951,722 
Capital expenditure  $2,392   $-   $2,392 

 

 

DSWISS, INC.

NOTES TO CONDENSED CONSOILIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2025

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

 

By Business Unit  Investment
holding		   Health care
products
and services		   Total 
   For the period ended June 30, 2024 
By Business Unit  Investment
holding		   Health care
products
and services		   Total 
             
Revenue  $-   $1,050,744   $1,050,744 
Cost of revenue   -    (648,674)   (648,674)
Gross profit   -    402,070    402,070 
Selling, general and administrative expenses and other income   (36,197)   (161,289)   (197,486)
Operating expenses   -    (587)   (587)
Finance cost   -    (643)   (643)
(Loss)/Profit from operations   (36,197)   239,551    203,354 
                
Total assets  $28,546   $542,826   $571,372 
Capital expenditure  $-   $-   $- 

 

By Country  Malaysia   Non-Malaysia   Total 
   For the period ended June 30, 2024 
By Country  Malaysia   Non-Malaysia   Total 
             
Revenue  $1,050,744   $-   $1,050,744 
Cost of revenue   (648,674)   -    (648,674)
Gross profit   402,070    -    402,070 
Selling, general and administrative expenses and other income   (159,872)   (37,614)   (197,486)
Operating expenses   -    (587)   (587)
Finance cost   (643)   -    (643)
Profit/(Loss) from operations   241,555    (38,201)   203,354 
                
Total assets  $518,853   $52,519   $571,372 
Capital expenditure  $-   $-   $-